Potential Surviving Effect of Cleome droserifolia Extract against Systemic Staphylococcus aureus Infection: Investigation of the Chemical Content of the Plant

Jawaher Alqahtani,Walaa A. Negm,Engy Elekhnawy,Ismail A. Hussein,Hassan Samy Hassan,Abdullah R. Alanzi,Ehssan Moglad,Rehab Ahmed,Sarah Ibrahim,Suzy A. El-Sherbeni
DOI: https://doi.org/10.3390/antibiotics13050450
2024-05-16
Antibiotics
Abstract:The increasing rates of morbidity and mortality owing to bacterial infections, particularly Staphylococcus aureus have necessitated finding solutions to face this issue. Thus, we elucidated the phytochemical constituents and antibacterial potential of Cleome droserifolia extract (CDE). Using LC-ESI-MS/MS, the main phytoconstituents of CDE were explored, which were kaempferol-3,7-O-bis-alpha-L-rhamnoside, isorhamnetin, cyanidin-3-glucoside, kaempferide, kaempferol-3-O-alpha-L-rhamnoside, caffeic acid, isoquercitrin, quinic acid, isocitrate, mannitol, apigenin, acacetin, and naringenin. The CDE exerted an antibacterial action on S. aureus isolates with minimum inhibitory concentrations ranging from 128 to 512 μg/mL. Also, CDE exhibited antibiofilm action using a crystal violet assay. A scanning electron microscope was employed to illuminate the effect of CDE on biofilm formation, and it considerably diminished S. aureus cell number in the biofilm. Moreover, qRT-PCR was performed to study the effect of CDE on biofilm gene expression (cna, fnbA, and icaA). The CDE revealed a downregulating effect on the studied biofilm genes in 43.48% of S. aureus isolates. Regarding the in vivo model, CDE significantly decreased the S. aureus burden in the liver and spleen of CDE-treated mice. Also, it significantly improved the mice's survival and substantially decreased the inflammatory markers (interleukin one beta and interleukin six) in the studied tissues. Furthermore, CDE has improved the histology and tumor necrosis factor alpha immunohistochemistry in the liver and spleen of the CDE-treated group. Thus, CDE could be considered a promising candidate for future antimicrobial drug discovery studies.
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?
### Problems the Paper Aims to Address This paper aims to explore the potential survival effects of **Cleome droserifolia** extract (CDE) against **Staphylococcus aureus** systemic infection and to investigate its chemical composition. #### Main Research Content: 1. **Chemical Composition Analysis**: Determine the main phytochemical components in CDE using liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) technology. 2. **Antibacterial Activity**: Evaluate the in vitro antibacterial effect of CDE against Staphylococcus aureus and its minimum inhibitory concentration (MIC) range. 3. **Anti-biofilm Activity**: Assess the impact of CDE on Staphylococcus aureus biofilm formation using crystal violet assay and scanning electron microscopy (SEM), and detect its effect on biofilm-related gene expression through real-time quantitative PCR (qRT-PCR). 4. **In Vivo Experiments**: Evaluate the therapeutic effect of CDE on Staphylococcus aureus systemic infection in a mouse model, including changes in bacterial load, survival rate, and inflammation markers. 5. **Histopathological and Immunohistochemical Studies**: Assess the pathological impact of CDE on liver and spleen tissues and the expression of tumor necrosis factor-α (TNF-α). ### Research Background Due to the rising morbidity and mortality caused by bacterial infections, especially Staphylococcus aureus, finding new antibacterial drugs has become crucial. This paper aims to provide new insights for the development of future antibacterial drugs by studying the chemical composition and antibacterial potential of CDE.